Melatonin, Neuroprotective Agents and Antidepressant Therapy

Автор: daromir от 18-10-2018, 19:20, Коментариев: 0

Категория: КНИГИ » ЗДОРОВЬЕ И МЕДИЦИНА


Автор: Francisco L?pez-Mu?oz, Venkataramanujam Srinivasan, Domenico de Berardis
Название: Melatonin, Neuroprotective Agents and Antidepressant Therapy
Издательство: Springer
Год: 2016
ISBN: 9788132228011
Язык: English
Формат: pdf
Размер: 29,7 mb
Страниц: 921

Mood disorders such as major depressive disorder (MDD), bipolar disorder (BPD) and seasonal affective disorder (SAD) are the most disabling disorders that are among the most expensive of all medical illnesses. The pathophysiology of mood disorders is very complex and involves many mechanisms like circadian rhythm disruption, sleep abnormalities, melatonin rhythm abnormalities and alterations in melatonin receptor mechanisms, abnormalities in monoaminergic neurotransmitter mechanisms, glutamatergic release mechanisms, hippocampal neurogenesis, and abnormal immune and cytokine release mechanisms.

Many antidepressants that are in clinical use today including the recently introduced novel agents like agomelatine or other antidepressants cause clinical remission by resynchronizing disrupted circadian rhythms and melatonin receptor functions, enhancing monoaminergic neurotransmission, promoting hippocampal neurogenesis, and regulating immune mechanisms.

This book explains various etiological factors that are involved in the pathogenesis of mood disorders and the mechanisms of therapeutic actions of antidepressants including the recently introduced agomelatine and other antidepressants that exhibit rapid onset of action with greater efficacy and fewer side effects.




ОТСУТСТВУЕТ ССЫЛКА/ НЕ РАБОЧАЯ ССЫЛКА ЕСТЬ РЕШЕНИЕ, ПИШИМ СЮДА!


Нашел ошибку? Есть жалоба? Жми!
Пожаловаться администрации
Уважаемый посетитель, Вы зашли на сайт как незарегистрированный пользователь.
Мы рекомендуем Вам зарегистрироваться либо войти на сайт под своим именем.
Информация
Посетители, находящиеся в группе Гости, не могут оставлять комментарии к данной публикации.